Salivary Oxytocin Levels Lower in Children with ASD, Correlate with Self-Esteem and Social Support
Background
The autism spectrum disorder (ASD) is characterized by significant social and emotional difficulties, with growing evidence pointing to dysregulation in the oxytocinergic and immune systems. While oxytocin, a crucial neuropeptide, is known for its role in social behavior, the precise associations between endogenous oxytocin levels, inflammatory markers, and internal psychological constructs like self-esteem and social support in ASD remain unclear. Current understanding suggests that atypical oxytocinergic functioning contributes to ASD pathophysiology, but the direct links to specific socio-emotional outcomes and the interplay with inflammatory pathways like IL-1β, IL-6, and IL-8 require further elucidation.
Study Design
This study included 26 children and adolescents with ASD and 23 typically developing (TD) controls to investigate the relationship between salivary oxytocin (OT) levels, inflammatory markers, self-esteem, and perceived social support. Salivary oxytocin and inflammatory cytokine levels (IL-1β, IL-6, IL-8) were quantified using enzyme-linked immunosorbent assays and multiplex immunoassays. The primary objective was to examine how these biological factors correlate with psychological measures of socio-emotional functioning across both groups, adjusting for age. Participants completed questionnaires assessing self-esteem and perceived social support.
Results
Salivary oxytocin levels were significantly lower in the ASD group compared to the TD group after adjusting for age, indicating a potential biological marker for socio-emotional challenges in ASD. In contrast, no significant group differences were observed in the measured inflammatory markers, including IL-1β, IL-6, or IL-8, suggesting these specific cytokines may not be primary drivers of the observed socio-emotional differences in this cohort. Importantly, across all 49 participants, including those with ASD, higher salivary oxytocin levels were consistently associated with greater self-esteem and perceived social support. This association highlights oxytocin's broad role in psychological well-being, irrespective of diagnostic status.
Participants with higher OT levels were associated with greater self-esteem and perceived social support, underscoring oxytocin's role in positive socio-emotional outcomes. Among the inflammatory markers, none of the cytokines (
IL-1β,IL-6, orIL-8) showed significant associations with the psychological measures, includingAQ-Jtotal scores, further differentiating the roles of oxytocin and inflammation in socio-emotional functioning.
Key Findings
- Salivary oxytocin levels were significantly lower in children/adolescents with ASD compared to typically developing controls.
- No significant group differences were found in inflammatory markers (
IL-1β,IL-6,IL-8) between ASD and TD groups. - Higher salivary oxytocin levels correlated with greater self-esteem across all participants.
- Higher salivary oxytocin levels correlated with greater perceived social support across all participants.
- Inflammatory markers (
IL-1β,IL-6,IL-8) showed no significant association with psychological measures.
Why It Matters
This research reinforces the critical role of endogenous oxytocin in socio-emotional functioning and psychological well-being across children and adolescents, including those with autism spectrum disorder. The finding that lower salivary oxytocin levels are associated with ASD, and that higher levels correlate with improved self-esteem and social support, suggests that interventions targeting the oxytocinergic system could hold therapeutic potential for enhancing socio-emotional outcomes. While this study does not involve exogenous oxytocin administration, it provides a rationale for exploring such interventions. Monitoring endogenous oxytocin levels could become a valuable biomarker for assessing socio-emotional health and potentially guiding personalized therapeutic strategies in ASD. Further research is needed to determine if increasing oxytocin levels through pharmacological or behavioral means can causally improve these outcomes, moving towards a usable protocol.
oxytocin
autism-spectrum-disorder
asd
social-cognition
self-esteem
social-support